ASRS 2023: Annexon to share results of ARCHER Phase 2 trial for the treatment of geographic atrophy
The presenter, Jeffrey S. Heier, MD, Director of the Retina Service and Retina Research, Ophthalmic Consultants of Boston, and an investigator in ARCHER will deliver the data on July 30, 2023.
The presenter, Jeffrey S. Heier, MD, Director of the Retina Service and Retina Research, Ophthalmic Consultants of Boston, and an investigator in ARCHER will deliver the data on July 30, 2023 at 9:00 am PT. (Image Credit: ©Kasto - Adobe.Stock.com)
Annexon, Inc. will present results from the ongoing ARCHER Phase 2 trial in patients with geographic atrophy (GA) at the American Society of Retina Specialists (ASRS) 2023 Annual Meeting. This meeting will take place July 28 – August 1, 2023 in Seattle, Washington.
The company’s presentation details are as follows:
- Date and Time: Sunday, July 30, 2023 at 9:00 am PT
- Title: Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration with Intravitreal ANX007: Results of the ARCHER Study
- Presenter: Jeffrey S. Heier, MD, Director of the Retina Service and Retina Research, Ophthalmic Consultants of Boston, and an investigator in ARCHER
- Session: Dry AMD Symposium 2
In addition to this presentation, the Annexon management will host a conference call, joined by Heier, on Monday, July 31, 2023 at 1:30 pm PT. The webcast and accompanying slides will be available under the Events & Presentations section on the Investors & Media page at www.annexonbio.com. A replay of the webcast will be archived on the Annexon website for 30 days.
